SALT LAKE CITY, Dec. 9, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of ...
MOORESTOWN, N.J., June 17, 2021 /PRNewswire/ — DCN Dx, an international provider of point-of-care diagnostics development, products, and educational programming, today announced it has completed its ...
CARLSBAD, Calif., June 30, 2021 /PRNewswire/ -- DCN Dx, an international provider of point-of-care diagnostics development, products, and educational programming, today announced it has completed its ...
The MarketWatch News Department was not involved in the creation of this content. OXFORD, United Kingdom, July 16, 2025 (GLOBE NEWSWIRE) -- Vivid Dx, a precision diagnostics company transforming ...
The Company intends to use the funds awarded by the National Institutes of Health for completion of its upper respiratory panel multiplex on Co-Dx PCR Home™ platform SALT LAKE CITY, July 13, 2023 ...
The Ecosystem for Pathology Diagnostics with AI Assistance (EMPAIA), an international organization that advances the use of validated AI solutions in clinical practice, has announced that Epredia, a ...
Company forms new AI business unit, led by Chief Technology & AI Officer Christopher Thurston, to unify and advance Co-Dx's existing and future AI initiatives SALT LAKE CITY, Nov. 3, 2025 /PRNewswire/ ...
SALT LAKE CITY, Aug. 18, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of ...
Test Designed to Assist in Identifying Severe Inflammatory Response in Patients with Confirmed COVID-19 Illness TORONTO, April 1, 2021 /CNW/ - SQI Diagnostics Inc. (the "Company" or "SQI") (TSXV: SQD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results